AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2020
Sep 17, 2020
33153_dirs_2020-09-17_a7b66a26-01e8-44f6-b435-4509ba1282ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2020-09-15
Reporting Person: Owens Gary M (President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-15 | Common Stock | M | 1720 | — | Acquired | 12720 | Direct |
| 2020-09-15 | Common Stock | F | 757 | $246.48 | Disposed | 11963 | Direct |
| 2020-09-16 | Common Stock | S | 100 | $249.32 | Disposed | 11863 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-09-15 | Restricted Stock Units - 1 | $ | M | 1720 | Disposed | Common Stock (1720) | Direct |
Footnotes
F1: Each RSU represents a contingency to receive one share of the Issuer's common stock
F2: RSUs that vest 1/3 on September 15, 2018 and each of the next two anniversary dates
F3: Not Applicable
F4: Represents shares of common stock retained by Mesa Labs for tax withholding purposes in connection with the net-settlement on the issuance of shares of common stock in respect to vested RSUs
F5: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23, 2020
More from MESA LABORATORIES INC /CO/
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6